This study aims to characterize the pediatric cryptosporidiosis disease profile with respect to clinical presentation.
Inclusion criteria:
Exclusion criteria:
Other protocol-defined inclusion/exclusion criteria may apply.
novartis.email@novartis.com+41613241111
Pediatric participants with diarrhea due to Cryptosporidium infection.
Transmission and the Respiratory Tract in Cryptosporidiosis
Cryptosporidiosis and Enteropathogens in Bangladesh
Study Testing the Efficacy, Safety, and Tolerability of EDI048 in Cryptosporidium Infection Model in Healthy Adults
Field Studies of Amebiasis in Bangladesh
Trial of Ceramic Water Filters to Reduce Cryptosporidium Infection in Kenya
A Phase 2A Evaluation of the Safety, Tolerability, Pharmacokinetics, Efficacy of Clofazimine (CFZ) in Cryptosporidiosis
Parasitic Causes of Secretory Diarrhea in Children and Chronically Ill Adult.
Treatment of Cryptosporidiosis